{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:13:29Z","timestamp":1782742409425,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.diabres.2024.111751","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T23:20:36Z","timestamp":1718839236000},"page":"111751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The association between glycated hemoglobin levels and long-term prognosis in patients with diabetes and triple-vessel coronary disease across different age groups: A cohort study"],"prefix":"10.1016","volume":"213","author":[{"given":"Qinxue","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deshan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guyu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianjun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutai","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runlin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3740-5103","authenticated-orcid":false,"given":"Jinqing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.diabres.2024.111751_b0005","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2011.02.074","volume":"58","author":"Min","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.diabres.2024.111751_b0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jacc.2008.03.051","article-title":"Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials","volume":"52","author":"Nicholls","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.diabres.2024.111751_b0015","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.297.16.1775","article-title":"Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial","volume":"297","author":"Morrow","year":"2007","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.diabres.2024.111751_b0020","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.amjcard.2011.10.018","article-title":"Influence of diabetes mellitus on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction","volume":"109","author":"Jensen","year":"2012","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.diabres.2024.111751_b0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.diabres.2009.05.010","article-title":"The comparison of coronary angiographic profiles between diabetic and nondiabetic patients with coronary artery disease in a Chinese population","volume":"85","author":"Gui","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"10.1016\/j.diabres.2024.111751_b0030","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1177\/000331979905001205","article-title":"Angiographic study of coronary artery disease in diabetic patients in comparison with nondiabetic patients","volume":"50","author":"Melidonis","year":"1999","journal-title":"Angiology"},{"issue":"5","key":"10.1016\/j.diabres.2024.111751_b0035","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s001250051352","article-title":"Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome","volume":"43","author":"Natali","year":"2000","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.diabres.2024.111751_b0040","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM198402093100602","article-title":"The clinical information value of the glycosylated hemoglobin assay","volume":"310","author":"Nathan","year":"1984","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.diabres.2024.111751_b0045","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.diabres.2024.111751_b0050","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.diabres.2024.111751_b0055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.diabres.2024.111751_b0060","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S2213-8587(17)30104-3","article-title":"Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials","volume":"5","author":"Zoungas","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"39","key":"10.1016\/j.diabres.2024.111751_b0065","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1016\/j.diabres.2024.111751_b0070","doi-asserted-by":"crossref","first-page":"e779","DOI":"10.1161\/CIR.0000000000000766","article-title":"Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association","volume":"141","author":"Arnold","year":"2020","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.diabres.2024.111751_b0075","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12933-023-01875-8","article-title":"Intensified glycemic control by HbA1c for patients with coronary heart disease and Type 2 diabetes: a review of findings and conclusions","volume":"22","author":"Chen","year":"2023","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"10.1016\/j.diabres.2024.111751_b0080","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/ejhf.1958","article-title":"Association between glycated haemoglobin levels and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the TECOS randomized clinical trial","volume":"22","author":"McAlister","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.diabres.2024.111751_b0085","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12933-021-01428-x","article-title":"J-curve relationship between long term glycemic control and mortality in diabetic patients with acute myocardial infarction undergoing percutaneous coronary intervention","volume":"20","author":"Choi","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.diabres.2024.111751_b0090","doi-asserted-by":"crossref","first-page":"e1919666","DOI":"10.1001\/jamanetworkopen.2019.19666","article-title":"Association of Longitudinal Values of Glycated Hemoglobin With Cardiovascular Events in Patients With Type 2 Diabetes and Multivessel Coronary Artery Disease","volume":"3","author":"Rezende","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.diabres.2024.111751_b0095","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1006524","article-title":"Long-term effects of intensive glucose lowering on cardiovascular outcomes","volume":"364","author":"Gerstein","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.diabres.2024.111751_b0100","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2337\/dc09-1278","article-title":"Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial","volume":"33","author":"Riddle","year":"2010","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.diabres.2024.111751_b0105","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jama.2016.0299","article-title":"Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes","volume":"315","author":"Lipska","year":"2016","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.diabres.2024.111751_b0110","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41574-021-00512-2","article-title":"Type 2 diabetes mellitus in older adults: clinical considerations and management","volume":"17","author":"Bellary","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"22","key":"10.1016\/j.diabres.2024.111751_b0115","article-title":"Control level of type 2 diabetes mellitus in the elderly is associated with polypharmacy, accompanied comorbidities, and various increased risks according to the beers criteria","volume":"13","author":"Atak Tel","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"Suppl 1","key":"10.1016\/j.diabres.2024.111751_b0120","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.2337\/dc24-S013","article-title":"13. Older Adults: Standards of Care in Diabetes-2024","volume":"47","author":"American Diabetes Association Professional Practice Committee.","year":"2024","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.diabres.2024.111751_b0130","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.2337\/dc21-0292","article-title":"Increased hemoglobin A(1c) time in range reduces adverse health outcomes in older adults with diabetes","volume":"44","author":"Prentice","year":"2021","journal-title":"Diabetes Care"},{"issue":"22","key":"10.1016\/j.diabres.2024.111751_b0135","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.diabres.2024.111751_b0140","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"issue":"10157","key":"10.1016\/j.diabres.2024.111751_b0145","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(18)32261-X","article-title":"Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial","volume":"392","author":"Hernandez","year":"2018","journal-title":"Lancet"},{"issue":"10193","key":"10.1016\/j.diabres.2024.111751_b0150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.diabres.2024.111751_b0155","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s11606-013-2595-x","article-title":"Pitfalls in hemoglobin A1c measurement: when results may be misleading","volume":"29","author":"Radin","year":"2014","journal-title":"J Gen Intern Med"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822724006612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822724006612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T03:34:55Z","timestamp":1721446495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822724006612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":30,"alternative-id":["S0168822724006612"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2024.111751","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between glycated hemoglobin levels and long-term prognosis in patients with diabetes and triple-vessel coronary disease across different age groups: A cohort study","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2024.111751","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111751"}}